These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24658193)

  • 41. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
    Agarwal AK
    J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S7-S12; quiz S17-21. PubMed ID: 17098634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease.
    Hertel JE; Locay HR; Scarlata DS; Prathikanti R; Audhya PK
    Mayo Clin Proc; 2006 Sep; 81(9):1188-94. PubMed ID: 16970215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study.
    Iimori S; Naito S; Noda Y; Nishida H; Kihira H; Yui N; Okado T; Sasaki S; Uchida S; Rai T
    Nephrology (Carlton); 2015 Sep; 20(9):601-8. PubMed ID: 25917812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron status and benefit of the use of parenteral iron therapy in pre-dialysis Chronic Kidney disease patients.
    Arogundade FA; Soyinka FO; Sanusi AA; Ojo OE; Akinsola A
    Niger Postgrad Med J; 2013 Dec; 20(4):299-304. PubMed ID: 24633272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study.
    de Francisco AL; Sulowicz W; Klinger M; Niemczyk S; Vargemezis V; Metivier F; Dougherty FC; Oguey D;
    Int J Clin Pract; 2006 Dec; 60(12):1687-96. PubMed ID: 17109676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conversion from epoetin and darbepoetin to C.E.R.A. in non-dialysis CKD patients: a multicenter Italian prospective study in nephrology practice.
    Minutolo R; Conte G; Cozzolino M; Polito P; Manno C; Di Iorio BR; Santoro D; Di Luca M; Nappi F; Feriozzi S; Sasso FC; De Nicola L
    Blood Purif; 2013; 36(2):69-77. PubMed ID: 23989045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The therapeutic management and economic burden of patients with chronic kidney disease non-dialysis-dependent with anemia and ESA treated: findings from a real-world study in Italy].
    Ravera M; Mené P; Degli Esposti L; Sangiorgi D; Di Rienzo P
    G Ital Nefrol; 2023 Feb; 40(1):. PubMed ID: 36883922
    [No Abstract]   [Full Text] [Related]  

  • 49. Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data.
    Dmitrieva O; de Lusignan S; Macdougall IC; Gallagher H; Tomson C; Harris K; Desombre T; Goldsmith D
    BMC Nephrol; 2013 Jan; 14():24. PubMed ID: 23351270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999-2018 National Health and Nutrition Examination Survey.
    Kovesdy CP; Davis JR; Duling I; Little DJ
    Clin Kidney J; 2023 Feb; 16(2):303-311. PubMed ID: 36755833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-Life Anemia Management Among Patients with Non-Dialysis-Dependent Chronic Kidney Disease in Three European Countries.
    Fliser D; Mata Lorenzo M; Houghton K; Ainsworth C; Blogg M; González de Antona Sánchez E; Portoles J
    Int J Nephrol Renovasc Dis; 2023; 16():115-129. PubMed ID: 37077414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study.
    New JP; Aung T; Baker PG; Yongsheng G; Pylypczuk R; Houghton J; Rudenski A; New RP; Hegarty J; Gibson JM; O'Donoghue DJ; Buchan IE
    Diabet Med; 2008 May; 25(5):564-9. PubMed ID: 18445169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study.
    Cases A; Portolés J; Calls J; Martinez-Castelao A; Munar MA; Segarra A
    Int Urol Nephrol; 2014 Oct; 46(10):1983-95. PubMed ID: 25118611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study.
    Stack AG; Alghali A; Li X; Ferguson JP; Casserly LF; Cronin CJ; Reddan DN; Hussein W; Elsayed ME
    Clin Kidney J; 2018 Feb; 11(1):99-107. PubMed ID: 29423209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society Anaemia Group.
    Cases A; Puchades MJ; de Sequera P; Quiroga B; Martin-Rodriguez L; Gorriz JL; Portolés J;
    Nefrologia (Engl Ed); 2021; 41(2):123-136. PubMed ID: 36166211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of anaemia in French dialysis patients: results from a large epidemiological retrospective study.
    Zaoui P; Courivaud C; Rostoker G; Choukroun G; Dubel L; Lorenzo M; Harmand S; Menoyo Calonge V
    Clin Kidney J; 2023 Mar; 16(3):501-511. PubMed ID: 36865005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study.
    Martínez-Castelao A; Górriz JL; Portolés JM; De Alvaro F; Cases A; Luño J; Navarro-González JF; Montes R; De la Cruz-Troca JJ; Natarajan A; Batlle D
    BMC Nephrol; 2011 Oct; 12():53. PubMed ID: 21970625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study.
    Portela F; Lago P; Cotter J; Gonçalves R; Vasconcelos H; Ministro P; Lopes S; Eusébio M; Morna H; Cravo M; Peixe P; Cremmers I; Sousa H; Deus J; Duarte M; Magro F;
    Digestion; 2016; 93(3):214-20. PubMed ID: 27022722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.
    Steegmann JL; Sánchez Torres JM; Colomer R; Vaz Á; López J; Jalón I; Provencio M; González-Martín A; Pérez M
    Clin Transl Oncol; 2013 Jun; 15(6):477-83. PubMed ID: 23263906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of the esa resistance index to guide dosing for anaemia management.
    Ross EA; Paugh-Miller JL; Wen X; Nappo RW
    J Ren Care; 2020 Dec; 46(4):216-221. PubMed ID: 32219971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.